Intellectual Property, Information Technology & Cybersecurity

Contact: Vivien Chan & Co. (Hong Kong)

China is one of the major producers of pharmaceuticals in the world and its pharmaceutical industry is a key contributor to the country’s rapid economic growth.

  However, counterfeits of pharmaceuticals are common.  Most would attribute the problem to the inadequate protection of intellectual property rights in the industry.  However, in fact, this industry, from the naming of a single drug to the innovative development of new pharmaceutical technology, is interwoven with IP issues.  This newsletter discusses the IP protection offered under the current IP regime in China. Click here to read entire article.